BioSpace News Archive

Genetown

Rubius Therapeutics to Provide Strategic Update

Rubius Therapeutics, Inc. (Nasdaq: RUBY) today announced that the Company plans to provide a strategic update and host an investor teleconference and webcast on Tuesday, September 13, 2022, at 7:30 a.m. EDT.

September 12, 2022
·
1 min read
Bone Growth Stimulators Market Size to Hit USD 3.8 Billion by 2030

According to Nova one advisor, the global Bone Growth Stimulators market was valued at USD 1.95 billion in 2021 and it is expected to hit around USD 3.8 billion by 2030 with a CAGR of 7.69% during the forecast period 2022 to 2030.

September 12, 2022
·
11 min read
Infectious Disease Therapeutics Market Size To Surpass USD 167 BN By 2030

The global Infectious Disease Therapeutics market size was estimated at USD 115 billion in 2021 and is expected to surpass around USD 167 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 4.23% during the forecast period 2022 to 2030.

September 12, 2022
·
9 min read
Plasma Derived Therapy Market Size to Surpass USD 33.75 Bn by 2030

According to the global Plasma Derived Therapy market size was estimated at USD 18.25 billion in 2021 and is expected to surpass around USD 33.75 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 7.07% during the forecast period 2022 to 2030

September 12, 2022
·
8 min read
C-mo Medical Solutions raises €4.1 million aiming to transform cough monitoring

C-mo Medical Solutions is an award-winning start-up that is unravelling the potential of assessing cough towards improved diagnosis, treatment courses and disease management.

September 12, 2022
·
5 min read
Genetown

Apellis Pharmaceuticals Announces New Presentation Time at the Bank of America Global Healthcare Conference

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced updated timing for its fireside chat at an upcoming investor conference hosted by Bank of America.

September 12, 2022
·
1 min read
Business

ERYTECH Provides Business and Financial Update for the First Half of 2022

ERYTECH Pharma,aclinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, provided a business and financial updatefor the first half of2022.

September 12, 2022
·
12 min read
Genetown

Codiak Announces Proposed Public Offering of Common Stock and Warrants - September 12, 2022

Codiak BioSciences, Inc. announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock and accompanying warrants to purchase shares of common stock in an underwritten public offering.

September 12, 2022
·
3 min read
Biotech Bay

AMGEN ANNOUNCES WEBCAST OF 2022 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

Amgen (NASDAQ:AMGN) will present at Bank of America Merrill Lynch’s 2022 Global Healthcare Conference at 4:55 a.m. ET on Thursday, Sept. 15, 2022.

September 12, 2022
·
2 min read
Business

Allarity Therapeutics Announces Appointment of New Auditor

Allarity Therapeutics, Inc. announced the appointment of Wolf & Company, P.C. as the Company’s independent registered public accounting firm effective immediately.

September 12, 2022
·
6 min read